Results 211 to 220 of about 152,993 (306)
Rational design and synthesis of narrow-band emitting Eu(II)-based hybrid halides via alkyl thermal cleavage. [PDF]
Li L, Jin J, Han K, Wang Y, Xia Z.
europepmc +1 more source
A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak +8 more
wiley +1 more source
Pseudomonas putida JM37 as a novel bacterial chassis for ethylene glycol upcycling
Molpeceres-García FJ +6 more
europepmc +1 more source
Interoperable Traceability in Agrifood Supply Chains: Enhancing Transport Systems Through IoT Sensor Data, Blockchain, and DataSpace. [PDF]
Farina G +20 more
europepmc +1 more source
Spain at the vanguard in European gender equality policies [PDF]
Valiente Fernández, Celia
core +2 more sources
Implementation of the EU-DEMO Exhaust Modelling Roadmap
Wiesen, S +13 more
openaire +1 more source
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié +16 more
wiley +1 more source
Novel archaeal ribosome dimerization factor facilitating unique 30S-30S dimerization. [PDF]
Hassan AH +6 more
europepmc +1 more source
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source

